These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2080486)

  • 21. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA; Tamimi JJ; Salem II; Ibrahim H; Sallam AA
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigation on the bioequivalence of 2 oral preparations containing spironolactone and furosemide.
    Vergin H; Mahr G; Metz R; Eichinger A; Nitsche V
    Int J Clin Pharmacol Ther; 1998 Apr; 36(4):231-8. PubMed ID: 9587051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers.
    Penn R; Williams RX; Guha-Ray DK; Sawyers WG; Braun SL; Rains KT
    Clin Ther; 2006 Jan; 28(1):45-54. PubMed ID: 16490579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and bioavailability of different formulations of aciclovir.
    Vergin H; Kikuta C; Mascher H; Metz R
    Arzneimittelforschung; 1995 Apr; 45(4):508-15. PubMed ID: 7779152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioavailability of pseudoephedrine and triprolidine from combination and single-ingredient products.
    Williams BO; Liao SH; Lai AA; Arnold JD; Perkins JG; Blum MR; Findlay JW
    Clin Pharm; 1984; 3(6):638-43. PubMed ID: 6509877
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo/in vitro correlations for four differently dissolving ketorolac tablets.
    Gordon MS; Chowhan Z
    Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Study on the absolute bioavailability of quinine and theophylline from tablets after single dose oral administration as compared to intravenous infusion in healthy male non-smoking volunteers.
    Fuder H; Herzog R; Vaupel W; Wetzelsberger N; Lücker PW
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):651-60. PubMed ID: 7746027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
    Shah J; Wesnes KA; Kovelesky RA; Henney HR
    Clin Ther; 2006 Sep; 28(9):1308-17. PubMed ID: 17062304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioavailability of different forms of amoxycillin administered orally to dogs.
    Küng K; Wanner M
    Vet Rec; 1994 Dec; 135(23):552-4. PubMed ID: 7886889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy and tolerability of enalapril compared to altizide combined with spironolactone in patients with moderate arterial hypertension].
    Gibelin P; Durand P; Baudouy M; Camous JP; Morand P
    Ann Cardiol Angeiol (Paris); 1986 May; 35(5):279-83. PubMed ID: 3019212
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the bioequivalence of 4- and 8-mg benidipine tablets in healthy volunteers after a single oral dose.
    Kang WK; Yun HY; Kwon KI
    J Clin Pharm Ther; 2005 Feb; 30(1):85-90. PubMed ID: 15659008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Studies of biological availability. A critical assessment based on a study of spironolactone preparations].
    Rameis H; Bacher S
    Wien Med Wochenschr; 1988 Apr; 138(6-7):156-60. PubMed ID: 3394332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of the dissolution and bioavailability characteristics of three spironolactone tablet formulations, including preliminary data on two spironolactone metabolites.
    Tidd MJ; Collins WT; Chamberlain J
    J Int Med Res; 1976; 4(2):86-95. PubMed ID: 1037443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic profile of talipexole in healthy volunteers is not altered when it is co-administered with Madopar (co-beneldopa).
    Zhang TT; Song M; Hang TJ; Xu XF; Wen AD; Yang L; Jia L
    J Clin Pharm Ther; 2009 Jun; 34(3):345-54. PubMed ID: 19646081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative pharmacokinetics of two tablet formulations of Losartan: bioequivalence assessment.
    Tamimi JJ; Salem II; Mahmood Alam S; Zaman Q; Dham R
    Biopharm Drug Dispos; 2005 Jul; 26(5):205-10. PubMed ID: 15906418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and bioavailability of oral acetylcysteine in healthy volunteers.
    De Caro L; Ghizzi A; Costa R; Longo A; Ventresca GP; Lodola E
    Arzneimittelforschung; 1989 Mar; 39(3):382-6. PubMed ID: 2757663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
    Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
    Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spironolactone. II. Bioavailability.
    Karim A; Zagarella J; Hutsell TC; Chao A; Baltes BJ
    Clin Pharmacol Ther; 1976 Feb; 19(2):170-6. PubMed ID: 1261154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.